Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
December 12, 2023 10:37 amButler J […] Wolf D […] Kosiborod MN. Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction. J Am Coll Cardiol 2023/82(22):2087-2096. doi: 10.1016/j.jacc.2023.09.811.
Categorised in:
This post was written by sfb1425
